explore -WSS

explore

author：Wikipedia 2025-10-02 05:55:01 - browse：245

LONDON — AstraZeneca said Tuesday it would acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on the booming area of targeted radiation therapies for cancer.

AstraZeneca will pay $2 billion in cash upfront for Fusion, a price that at $21 a share is nearly double Fusion’s closing share price on Monday. If certain regulatory milestones are met, AstraZeneca will pay another $3 a share, or roughly $400 million.

Fusion specializes in developing radiopharmaceuticals, also known as radioconjugates or radioligands, which deliver radiation directly to tumors, guided by particular markers on cancer cells. The aim is not only to minimize the risk of damaging surrounding, healthy tissue, but also to reach tumors that traditional radiation can’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： This gene therapy has record $4.25 million price. It's saved children.

explore

entertainment

WSS

Guardant Health colon cancer test endorsed by FDA advisory panel

Should insurance cover cosmetic surgery?

Why we need mandatory labeling of GMO products

Why some fertility treatments produce more boy babies

Why we need mandatory labeling of GMO products

Protect nursing home residents from future pandemics

focus

explore

leisure time

Virginia high school admissions case could be legal follow

6 surprising facts about sugar

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Anesthesiologist group: stop taking Ozempic before surgery

'Patient friction coefficient' can gauge a clinical trial's patient burden

Jerome Adams on the need for new antivirals for Covid

Ozempic cut risk of death in diabetes patients with chronic kidney disease

How one medical school became remarkably diverse

New research sheds light on how often breast cancer is overdiagnosed

leisure time

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Beyond aggravation: Constipation is an American epidemic

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Adam's Take: Intra

Diabetes management: Digital health tools fall short, study says

Congress: Prevent baby formula shortages by passing a new bill

explore

entertainment

focus

leisure time